Related Experiment Video
Updated: Jul 25, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Rare alpha-1-antitrypsin phenotypes and liver-test abnormalities during infancy
1Department of Paediatrics, Regional Hospital, Bozen, Italy. pediat@asbz.provincia.bz.it
Insights
Neonatal screening identified rare alpha-1-antitrypsin (alpha1-AT) deficiency carriers. Early detection of PiFZ and PiPZ phenotypes allows for interventions to mitigate risks like pulmonary emphysema.
Area of Science:
- Medical Genetics
- Neonatal Screening
- Pulmonary Medicine
Background:
- Alpha-1-antitrypsin (alpha1-AT) deficiency is a genetic condition increasing risk for lung and liver diseases.
- Neonatal screening is crucial for early identification of genetic disorders.
- Phenotyping allows for the identification of specific alpha1-AT alleles.
Purpose of the Study:
- To evaluate the effectiveness of neonatal screening for alpha-1-antitrypsin (alpha1-AT) alleles.
- To identify infants with abnormal alpha1-AT phenotypes and assess associated risks.
- To determine the prevalence of rare alpha1-AT phenotypes in a Northern Italian population.
Main Methods:
- Analysis of 71,675 dried blood samples from neonatal screening over 14 years.
- Isoelectric focusing used to determine alpha1-AT alleles.
- Liver enzymes (alanine aminotransferase, gamma-glutamyltransferase) measured in infants with abnormal phenotypes.
Main Results:
- Identified 17 PiMV, 11 PiMF, 11 PiMP, 5 PiMN, 3 PiMR, 3 PiFZ, 2 PiPZ, and 1 PiMG phenotypes.
- Two infants (PiMV, PiFZ) showed elevated liver enzymes.
- PiFZ and PiPZ carriers had low alpha1-AT levels (0.78 and 0.85 g/L), indicating a risk for pulmonary emphysema.
Conclusions:
- Neonatal screening based on phenotyping is effective in early detection of rare alpha1-AT deficiency carriers.
- Early identification of at-risk individuals (e.g., PiFZ, PiPZ) enables preventative measures, such as discouraging smoking.
- This screening approach facilitates timely medical intervention for alpha1-AT deficiency.
Unlabelled:
Over 14 y of neonatal screening 71,675 dried blood samples were examined for the alpha-1-antitrypsin (alpha1-AT) alleles by isoelectric focusing in the Province of Bozen, Northern Italy. In infants carrying abnormal phenotypes the liver enzymes alanine aminotransferase and gamma-glutamyltransferase were determined at 2, 5 and 12 mo of age. In 17 neonates the PiMV phenotype was found, in 11 PiMF, in 11 PiMP, in 5 PiMN, in 3 PiMR, in 3 PiFZ, in 2 PiPZ and in 1 the PiMG phenotype was found. Two infants,1 carrying the PiMV and 1 the PiFZ phenotype showed at the age of 2 and 5 mo, respectively, elevated values of the liver enzyme S-ALAT[CE1]. Only the PiFZ and PiPZ carriers displayed low enough levels of alpha1-AT of 0.78 and 0.85 g l(-1) respectively, to be at moderately increased risk of pulmonary emphysema. Their early detection through the screening should discourage them from dangerous smoking habits.
Conclusion:
Only a neonatal screening based on phenotyping can detect these rare carriers early in life.
Related Concept Videos
Pleiotropy
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

